The results showed that the weight of xenografts from YOD1 overexpressing SCC15 cells was notably lower than that come from control cells (Fig. 6B), indicating the tumor-suppressive effect of YOD1 on HNSCC tumor growth. This evidence concerns the gene YOD1 and head and neck squamous cell carcinoma.